TNXP - Tonix Pharmaceuticals Holding Corp.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.94M
Enterprise Value 3-12.77M
Trailing P/E N/A
Forward P/E 1-0.17
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.16
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.50

Trading Information

Stock Price History

Beta (3Y Monthly) 1.04
52-Week Change 3-96.34%
S&P500 52-Week Change 31.11%
52 Week High 315.7000
52 Week Low 30.4300
50-Day Moving Average 30.7168
200-Day Moving Average 31.7320

Share Statistics

Avg Vol (3 month) 3565.03k
Avg Vol (10 day) 3100.78k
Shares Outstanding 57.83M
Float 5.65M
% Held by Insiders 11.77%
% Held by Institutions 19.96%
Shares Short (Jul 15, 2019) 4864.52k
Short Ratio (Jul 15, 2019) 42.59
Short % of Float (Jul 15, 2019) 414.55%
Short % of Shares Outstanding (Jul 15, 2019) 413.64%
Shares Short (prior month Jun 14, 2019) 4407.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Nov 28, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-78.14%
Return on Equity (ttm)-139.41%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -25.58M
Net Income Avi to Common (ttm)-28.65M
Diluted EPS (ttm)-13.5800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.45M
Total Cash Per Share (mrq)2.7
Total Debt (mrq)580k
Total Debt/Equity (mrq)3.26
Current Ratio (mrq)9.54
Book Value Per Share (mrq)2.92

Cash Flow Statement

Operating Cash Flow (ttm)-25.84M
Levered Free Cash Flow (ttm)-16.39M